Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardiff LexingtonCDIX +0.79%27 3-Year Book Growth Rate is 96.90% as of Mar. 2026, which is 1% above its 10-year median of 95.90. GuruFocus rates CDIX with a GF Score™ of 27/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Cardiff Lexington ranks better than 97.76% on this metric.
During the past 3 years, the average Book Value per Share Growth Rate was 96.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Cardiff Lexington was 96.90% per year. The lowest was 94.90% per year. And the median was 95.90% per year.
Cardiff Lexington (OTCPK:CDIX) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Cardiff Lexington 3-Year Book Growth Rate Related Terms
CDIX vs AMS, SYRA, BMGL: 3-Year Book Growth Rate Comparison
For the Medical Care Facilities subindustry, Cardiff Lexington's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardiff Lexington 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cardiff Lexington's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Cardiff Lexington's 3-Year Book Growth Rate falls into.
Cardiff Lexington 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 96.90% mean?
Cardiff Lexington (CDIX) has a 3-Year Book Growth Rate of 96.90% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Cardiff Lexington and its competitors. This is near median its historical median of 95.90. Over the past decade, Cardiff Lexington's 3-Year Book Growth Rate has ranged from 94.90 to 96.90. According to the industry distribution chart, Cardiff Lexington ranks #13 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 2.2%.
Is Cardiff Lexington's 3-Year Book Growth Rate too high?
Cardiff Lexington's current 3-Year Book Growth Rate of 96.90% is near median its 10-year median of 95.90. Over the past 10 years, this metric has ranged from a low of 94.90 to a high of 96.90. The Healthcare Providers & Services industry median 3-Year Book Growth Rate is 5.45. Cardiff Lexington's value of 96.90% is 1678% above this industry median. Based on the distribution chart, Cardiff Lexington ranks #13 out of 580 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cardiff Lexington has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardiff Lexington's 3-Year Book Growth Rate compare to AMS and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Cardiff Lexington ranks #13 out of 580 companies for 3-Year Book Growth Rate. This places Cardiff Lexington in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year Book Growth Rate is 5.45. Cardiff Lexington's value of 96.90% is 1678% above this benchmark. Historically, Cardiff Lexington's own 3-Year Book Growth Rate has ranged from 94.90 to 96.90 over the past decade. While the company's 10-year median is 95.90 vs. the industry median of 5.45, Cardiff Lexington has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.45, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardiff Lexington's current 3-Year Book Growth Rate of 96.90% is 1678% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Cardiff Lexington and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiff Lexington's current 3-Year Book Growth Rate is 96.90%, which is near median its own 10-year median of 95.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiff Lexington stock overvalued right now?
Based on GuruFocus' analysis, Cardiff Lexington (CDIX) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.51 — trading 537.5% above its estimated fair value. The current 3-Year Book Growth Rate is 96.90%, which is near median its 10-year median of 95.90 and 1678% above the Healthcare Providers & Services industry median of 5.45. Cardiff Lexington's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Cardiff Lexington (CDIX), the current 3-Year Book Growth Rate is 96.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardiff Lexington (CDIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardiff Lexington stock appears to be overvalued.
The current stock price of $0.51 is trading 537.5% above its estimated GF Value™ of $0.08.
GuruFocus considers Cardiff Lexington to be Significantly Overvalued.
Key valuation signals for CDIX:
3-Year Book Growth Rate: 96.90% (near median its 10-year median of 95.90)
GF Value™: $0.08 vs. price of $0.51 (537.5% above fair value)
Industry Position: 1678% above the Healthcare Providers & Services median (#13 of 580)
No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
27GF Score
Get the complete analysis for CDIX
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDIX has been successfully added to your 
